Lyka Labs Ltd

NSE: LYKALABS · BSE: 500259 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹81.35
Market cap: ₹290.3 Cr
Revenue (annual): ₹128.4 Cr
Net profit (annual): ₹-10.03 Cr
P/E (TTM): -68.2×Sector 43.8×
Promoter holding: 58.45%+0.00% QoQ
FII holding: 0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 5 Other Announcement 4 Price Movement Clarification 3 Board Meeting Date 3 Annual General Meeting 3 Results Update 2 Promoter Buying 2 Legal & Regulatory 2 Results Correction 1 Management Change 1 Fund Raise 1 Credit Rating 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Oct 2026 17:35 IST NSE

Results Update

Lyka Labs Results Update

Q2 FY27 standalone revenue rose 34.06% to Rs. 4,419.95 Lacs. Standalone net profit swung to Rs. 131.50 Lacs from a loss.

Open announcement → Read the filing ↗

10 Aug 2026 12:47 IST BSE

Results Update

Lyka Labs Results Update

Lyka Labs Limited reported its Q1 FY27 results with consolidated net total income of Rs. 42.73 Crore. Standalone net profit surged 159% year-on-year to Rs. 2.10 Crore.

Value: ₹42.73 Cr

Open announcement → Read the filing ↗